Administration of 5-fluorouracil (5-FU) to mice results in a marked increase in the level of circulating platelets in 10 days. Mice lacking Mpl, the receptor for thrombopoietin (TPO), are thrombocytopenic. To gain insight into the mechanism by which 5-FU produces such a substantial stimulation of platelet production, this study investigated whether 5-FU (150 mg/ kg) produced thrombocytosis in c-mpl ؊/؊ mice, thus establishing whether TPO was required for this response. A 5-to 6-fold increase in platelet levels in c-mpl ؊/؊ mice (to approximately 1000 ؋ 10 9 /L) was observed on days 20 and 25 after 5-FU injection. Thus, at the peak of the response, c-mpl ؊/؊ mice had platelet levels comparable to those in normal mice. Administration of 5-FU also produced thrombocytosis in previously splenectomized c-mpl ؊/؊ mice. Comparison of the platelet response to 5-FU in young (6-12 weeks) and old (33-46 weeks) c-mpl ؊/؊ mice found that older mice produced a much more marked response than younger mice, with a mean maximum platelet level of approximately 1700 ؋ 10 9 /L. To determine whether this increase in circulating platelets was preceded by an increase in hematopoietic progenitors, serial cultures of bone marrow and spleen were evaluated. A considerable increase in all colony types studied was observed on days 15 and 20 in spleens of c-mpl ؊/؊ mice, but no similar elevations were detected in bone marrow. These results indicate that c-mpl ؊/؊ mice can achieve a normal level of platelets after 5-FU injection, by means of a TPO-independent mechanism, and that they respond to 5-FU myelosuppression by producing large numbers of megakaryocytic, myeloid, and erythroid progenitors.
IntroductionThe myelosuppressive agent fluorouracil (5-FU) produces a unique effect on megakaryocytopoiesis. Administration to mice of a single dose of 150 mg/kg results in gradual development of moderate thrombocytopenia, with the nadir in platelet count occurring approximately 4 to 8 days after administration. [1][2][3] Subsequently, the level of circulating platelets increases rapidly and thrombocytosis develops by day 10. 1-3 Platelet levels as high as 3000 ϫ 10 9 /L to 3500 ϫ 10 9 /L are reached (normal platelet count in mice is 1000 ϫ 10 9 /L to 1200 ϫ 10 9 /L), and thrombocytosis persists from approximately day 10 to day 19.Changes in platelet levels are associated with a marked increase in the number of megakaryocytes (MKs) in both bone marrow and spleen, with the increase occurring in the bone marrow after 7 or 8 days 3,4 but in the spleen only after 12 days. 4 A marked increase in the frequency and total numbers of MK colony-forming cells (MK-CFCs) occurs in the spleen concurrent with the period of thrombocytosis. 2 Despite the increase in spleen size and numbers of splenic MK-CFCs, it was shown that the spleen is not required for production of the marked thrombocytosis after administration of 5-FU. 3,5 The mechanism by which 5-FU produces marked thrombocytosis is unknown. The minimal brief reduction in the concentration of recognizable MK...